亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Trigeminal Neuralgia

医学 可视模拟标度 随机对照试验 三叉神经痛 科克伦图书馆 置信区间 荟萃分析 麻醉 肉毒毒素 子群分析 内科学
作者
Xinyu Hu,Yun Xia,Jingwen Li,Xinyi Wang,Hanshu Liu,Jichuan Hu,Juan Bi,Jing Wu,Tao Wang,Zhicheng Lin,Nian Xiong
出处
期刊:The Clinical Journal of Pain [Lippincott Williams & Wilkins]
卷期号:40 (6): 383-392 被引量:1
标识
DOI:10.1097/ajp.0000000000001207
摘要

Objective: Pain management in patients with TN is challenging, as facial pain often does not respond well to conventional therapies. Botulinum toxin type A (BTX-A) has been suggested as a potential treatment option, but there is limited evidence regarding its long-term efficacy. This review aimed to analyze the current data for the use of in the treatment of trigeminal neuralgia (TN) and highlight the evidence for its efficacy and safety. Methods: A comprehensive search was conducted in various databases (PubMed, Scopus, Embase, ClinicalTrials, and Cochrane Library) to identify clinical studies evaluating the use of BTX-A in TN until October 2023. Randomized controlled trials (RCTs), single-arm studies, and stratified studies were included in the analysis. The mean difference (MD), effect size (ES), and 95% confidence interval (CI) were estimated for visual analogue scale (VAS) scores, pain episode frequency, and the proportion of responders. Results: The analysis included 23 studies, including 4 RCTs, 14 single-arm studies, and 5 stratified studies. In the RCTs, BTX-A was found to significantly reduce mean VAS scores compared with baseline (ES: −4.05; 95% CI: −6.13, −1.97; P =0.002). In 19 non-RCTs, the pooled single-arm analysis revealed that BTX-A decreased VAS scores (ES: -5.19, 95% CI: −6.05, −4.33, P <0.001) and pain attack frequency (ES: −17.85, 95% CI: −23.36, −12.34, P <0.001) from baseline to the end of follow-up. The overall proportion of responders to BTX-A treatment was also significant (95% CI: 0.653, 0.761, P =0.003). Discussion: Current evidence indicates that BTX-A injection is an effective and safe option for patients with refractory TN or not responding to medical or surgical management. However, more high-quality studies are needed to further confirm its efficacy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
2秒前
4秒前
5秒前
李爱国应助天真的大白菜采纳,获得10
5秒前
WUHUIWEN完成签到,获得积分10
5秒前
6秒前
7秒前
Vision820完成签到,获得积分10
9秒前
zzq发布了新的文献求助10
11秒前
充电宝应助摆渡人采纳,获得10
14秒前
千纸鹤完成签到 ,获得积分10
18秒前
传奇3应助科研通管家采纳,获得10
23秒前
烟花应助科研通管家采纳,获得10
23秒前
Kongstrue完成签到,获得积分10
25秒前
研友_LaOyQZ完成签到,获得积分10
28秒前
32秒前
蔚欢完成签到 ,获得积分10
34秒前
andrele发布了新的文献求助10
35秒前
36秒前
37秒前
丘比特应助优美一曲采纳,获得10
41秒前
Kongstrue发布了新的文献求助10
42秒前
哈哈哈哈发布了新的文献求助10
45秒前
YOLO完成签到,获得积分20
1分钟前
andrele发布了新的文献求助10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
李末完成签到 ,获得积分10
1分钟前
1分钟前
优美一曲发布了新的文献求助10
1分钟前
kdjm688发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
李健应助lf采纳,获得10
1分钟前
kdjm688发布了新的文献求助10
1分钟前
优美一曲完成签到,获得积分10
1分钟前
1分钟前
israr完成签到,获得积分10
1分钟前
lf发布了新的文献求助10
1分钟前
2分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976608
求助须知:如何正确求助?哪些是违规求助? 3520720
关于积分的说明 11204567
捐赠科研通 3257359
什么是DOI,文献DOI怎么找? 1798716
邀请新用户注册赠送积分活动 877897
科研通“疑难数据库(出版商)”最低求助积分说明 806613